July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has launched Mammogram+ and Mammogram+ Heart, two new AI-enhanced mammogram services aimed at improving early detection and advancing preventative care.
Mammogram+ is SimonMed’s most advanced breast cancer screening to date. By combining two AI technologies with expert breast radiologist review, Mammogram+ is designed to spot cancer earlier and deliver more personalized insights on their breast density, lifetime risk. This service replaces the previous PBCD (Personalized Breast Cancer Detection) program.
“At SimonMed Imaging, we’re focused on empowering women with the latest technology to take charge of their health,” said Dr. John Simon, CEO and Founder of SimonMed Imaging. “Mammogram+ and Mammogram+ Heart combine advanced AI to detect breast cancer earlier and identify early signs of heart disease—offering valuable insight into both breast and heart health through a single exam.”
Building on this new technology in breast health, Mammogram+ Heart enhances standard mammography by incorporating an AI-based assessment of Breast Arterial Calcification (BAC), an emerging clinical marker linked to cardiovascular risk in women. This dual-purpose screening enables detection of both breast cancer and early signs of heart disease in a single appointment.
Mammogram+ and Mammogram+ Heart are now available at SimonMed locations nationwide that offer mammography services. These are optional add-ons that can be included with a standard screening mammogram. No referral is needed for patients to include either service as part of their regular mammogram.
“Women deserve the best tools available when it comes to detecting disease early,” said Dr. Angela Fried, Director of Breast Imaging at SimonMed. “With Mammogram+ and Mammogram+ Heart, we’re offering more than a scan—we’re delivering deeper insight, earlier intervention, and more empowered care.”
This launch reflects SimonMed’s ongoing mission in AI-driven diagnostics, accessible innovation, and lifesaving screening tools designed around real patient needs. As breast cancer and cardiovascular disease diagnoses continue to rise, these newly added services aim to close the gap in early detection.
Learn more at www.simonmed.com.
June 30, 2026 
